Industry Experts - Market Research Reports, Industry Analysis, Custom Research

The latest version of the report from Industry Experts Inc, on “ Influenza Market ,” is unveiled. According to this new market research report, the global Influenza market size is estimated at US$9.6 billion in 2024 and expected to register a CAGR of 4.5% between 2024 and 2030 to reach US$12.4 billion in 2030. The influenza market is driven by global health initiatives, seasonal outbreaks of flu, and the need for preventive healthcare, leading to a steady demand for vaccines and antiviral treatments. Government immunization programs, increasing awareness, and ongoing R&D investments in vaccine innovation and pandemic preparedness are major market growth factors. Advancements in vaccine technology, such as recombinant and cell-based formulations, have improved the effectiveness and availability of vaccine agents. In 2024, the oseltamivir phosphate segment led the market with a 47.4% share thanks to its strong effectiveness, broad activity against influenza A & B,...

Industry Experts unveiled the new market research report on Influenza. The new global report ‘ Global Influenza Market – Vaccines and Therapeutics ’ reveals that the market for seasonal influenza vaccines is estimated at 543 million doses valued at US$4.9 billion in 2016 and projected to touch US$714 million doses equated to US$7.9 billion by 2022. In terms of market value, North America is estimated the largest market with US$2.1 billion in 2016 while Europe is projected to be the fastest growing market for Influenza vaccines during the analysis period 2016-2022 with a CAGR of 11.7%. The influenza virus has been implicated in infecting millions of individuals on an annual basis, with vaccination programs against seasonal influenza infections necessitating the manufacture of hundreds of million doses within a very short time period. The emergence of innovative production systems based on mammalian or insect cell cultures have resulted in surmount the hurdles associate...